NONE Pill — WHITE ROUND, 8mm — Potassium Chloride

No photo available
View full Potassium Chloride profile
ImprintNONE
ColourWHITE
ShapeROUND
Size8
StrengthCALCIUM FLUORIDE 12 [hp_X];CALCIUM PHOSPHATE 12 [hp_X];CALCIUM SULFATE 12 [hp_X];FERRUM PHOSPHORICUM 12 [hp_X];POTASSIUM CHLORIDE 12 [hp_X];POTASSIUM PHOSPHATE, DIBASIC 12 [hp_X];POTASSIUM SULFATE 12 [hp_X];MAGNESIUM PHOSPHATE, DIBASIC 12 [hp_X];SODIUM CHLORIDE 12 [hp_X];SODIUM PHOSPHATE, DIBASIC 12 [hp_X];SODIUM SULFATE 12 [hp_X];SILICON DIOXIDE 12 [hp_X]
Dosage formTablet, Chewable
ManufacturerHOMEOLAB USA INC
NDC60512-8036
Schedule—
Availability—
IngredientsCALCIUM FLUORIDE[FLUORIDE ION];CALCIUM PHOSPHATE[CALCIUM CATION];CALCIUM SULFATE[CALCIUM CATION];FERRUM PHOSPHORICUM[FERROSOFERRIC PHOSPHATE];POTASSIUM CHLORIDE[POTASSIUM CATION];POTASSIUM PHOSPHATE, DIBASIC[PHOSPHATE ION];POTASSIUM SULFATE[SULFATE ION];MAGNESIUM PHOSPHATE, DIBASIC[MAGNESIUM PHOSPHATE, DIBASIC];SODIUM CHLORIDE[CHLORIDE ION];SODIUM PHOSPHATE, DIBASIC[PHOSPHATE ION];SODIUM SULFATE[SODIUM SULFATE ANHYDROUS];SILICON DIOXIDE[COLLOIDAL SILICON DIOXIDE]

What does this imprint mean?

The imprint "NONE" is a code stamped or printed on the tablet or capsule by the manufacturer, used to identify the drug, its strength and the maker.

Active ingredient

Potassium Chloride

Uses and warnings

BOXED WARNING: "Because of reports of intestinal and gastric ulceration and bleeding with extended-release potassium chloride preparations, these drugs should be reserved for those patients who cannot tolerate or refuse to take liquid or effervescent potassium preparations, or for patients in whom these products are not appropriate." Contraindicated in hyperkalemia, which "can produce cardiac arrest," and in conditions predisposing to hyperkalemia; also contraindicated with gastrointestinal obstruction, delayed gastric emptying, or conditions slowing GI transit because of the ulcerogenic potential of concentrated potassium salts. Caution is advised with potassium-sparing diuretics, ACE inhibitors/ARBs, and in renal impairment.

Extended-release potassium chloride tablets are indicated for "treatment of patients with hypokalemia with or without metabolic alkalosis," including digitalis intoxication and hypokalemic familial periodic paralysis, and for "prevention of hypokalemia" in patients at risk, such as those on digitalis who would be endangered by even transient hypokalemia, or those with inadequate dietary potassium intake.

Read the full drug profile →

How to identify this pill

Similar-looking pills

Other pills of Potassium Chloride

Official references

Source: FDA Structured Product Label via NLM Pillbox archive (retired 2021); source file 600bb4d6-f18a-48a3-b89b-dcc12e7cb4b5.xml